J. Cukier et al., ASSOCIATION BETWEEN BOVINE COLLAGEN DERMAL IMPLANTS AND A DERMATOMYOSITIS OR A POLYMYOSITIS-LIKE SYNDROME, Annals of internal medicine, 118(12), 1993, pp. 920-928
Objective: To determine whether an excess incidence of dermatomyositis
or polymyositis or both exist in patients treated with injectable bov
ine collagen implants and to characterize the clinical picture. Design
: Historical cohort study (July 1980 through June 1988). Patients: Pat
ients were identified from personal experience or adverse reaction rep
orts received by the manufacturer. Setting: An 8-year period in the Un
ited States during which approximately 345 000 patients received impla
nts. Results: Eight patients with dermatomyositis and an additional pa
tient with polymyositis were identified from approximately 345 000 pat
ients receiving injectable bovine collagen implants from July 1980 thr
ough June 1988. The nine patients with dermatomyositis or polymyositis
were diagnosed an average of 6.4 months (range, 0.7 to 24.9 months) a
fter collagen implant or skin test exposure or both. Eight of the nine
patients had a delayed-type hypersensitivity response at the test or
treatment sites or both, and five of six patients tested were found to
have increased serum antibodies to collagen. Compared with the genera
l population, the incidence of dermatomyositis or polymyositis among c
ollagen-treated patients was statistically increased (standardized inc
idence ratio, 5.05; 95% CI, 2.31 to 9.59; P < 0.0001). A similar analy
sis of the eight dermatomyositis case patients produced a standardized
incidence ratio of 18.8 (CI, 8.1 to 37.0; P < 0.0001). Using a Monte
Carlo simulation, an interval of 6.4 months or less from exposure to o
nset of disease was found to be an extremely rare event, occurring les
s than 72 times per one million simulation trials (CI, 57 to 91). Conc
lusions: Because these data suggest that an immunologic response to bo
vine type I or type III collagen or both caused this dermatomyositis o
r polymyositis-like syndrome, the risks versus benefits for the cosmet
ic use of collagen implants should be reassessed.